TSMHT
VRTX icon

Thurston Springer Miller Herd & Titak’s Vertex Pharmaceuticals VRTX Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$1.21M Buy
2,727
+553
+25% +$246K 0.16% 151
2025
Q1 		$1.05M Buy
2,174
+405
+23% +$196K 0.18% 129
2024
Q4 		$712K Buy
1,769
+673
+61% +$271K 0.14% 151
2024
Q3 		$510K Buy
1,096
+175
+19% +$81.4K 0.14% 161
2024
Q2 		$432K Buy
+921
New +$432K 0.13% 157